Category: Countries
-

Annette Curry joins Control Bionics as Head of Sales – Australia
Control Bionics continues to expand our leadership team with new Head of Sales – Australia, Annette Curry. Annette brings years of experience as a nurse practitioner, sales and marketing leader.
-

Control Bionics Expands Management Team with Vice President – North America, Todd Tyler
Control Bionics is excited to announce the expansion of their management team with Vice President – North America, Todd Tyler.
-

Just Announced: Control Bionics to Present at Closing the Gap
Control Bionics will be giving three on-demand presentations at Closing the Gap, providing educational resources to those attending. Preview the presentations now, all presentations will be available October 11th. Register for the conference for access to the sessions.
-

Speak Up Podcast: Control Bionics Discusses Voice Banking with Speech Pathology Australia
On Wednesday, Control Bionics CEO, Rob Wong, was a guest on the Speak Up Podcast, discussing voice banking for people faced with losing their ability to speak.
-

Control Bionics Announces Reseller Agreement with DNR Wheels Pte Limited
Control Bionics has entered into a reseller agreement with DNR Wheels Pte Limited, a leading distributor in Singapore of mobility, homecare and rehabilitation equipment and technology. Read the Press Release.
-

Funding Made Easy: 3 Steps to Getting a Device
The first question we often get is “how much is a Control Bionics device?” We understand why: our technology has three powerful access methods and provides a lifetime solution for those with paralysis and loss of speech, so you might think it comes with a hefty price tag. The good news is that Control Bionics…
-

Control Bionics (ASX:CBL) Partners with Numotion as Northeastern US Reseller of Assistive Technology Solutions
Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is partnering with Numotion, a leading provider of Complex Rehab Technology (CRT) to offer the Control Bionics’ Trilogy product line.
-

Control Bionics set to enter the ASX bourse next week; inspired by Stephen Hawking and already FDA approved
Medtech company Control Bionics (ASX:CBL) will list on the ASX next week. The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so through electronic devices that pick up their neuroelectric systems. Examples of such conditions include motor-neuron disease, cerebral palsy, and spinal cord injuries. Control Bionics’ flagship product, NeuroNode 3, is watch-sized…
-

Medicare Approves Life-Changing Technology for People with Disabilities
The NeuroNode provides a new solution for those with ALS/MND, Cerebral Palsy and more. Milford, Ohio, October 26, 2018 — Control Bionics’ NeuroNode, a revolutionary life-altering assistive technology product, is universally available for people with disabilities. Control Bionics released the NeuroNode in January of 2017 at the ATIA (Assistive Technology Industry Association) in Orlando, Florida. The…
-

NeuroSwitch Featured at Florida Alliance for Assistive Services and Technology (FAAST)
CEO Peter Ford and NeuroSwitch user Michael Phillips, who has spinal muscular atrophy, recently attended the Florida Alliance for Assistive Services and Technology (FAAST) 20th anniversary event. In the photo below, Michael Phillips is controlling a virtual jet fighter, engaging and downing other aircraft, with a single NeuroSwitch control site on his forehead.


